On Thursday, Immunic Inc (IMUX) stock saw a modest uptick, ending the day at $1.59 which represents a slight increase of $0.05 or 3.25% from the prior close of $1.54. The stock opened at $1.54 and ...

On Tuesday, Senseonics Holdings Inc (SENS) stock saw a decline, ending the day at $0.35 which represents a decrease of $-0.01 or -2.78% from the prior close of $0.36. The stock opened at $0.36 and ...

On 3 rd June, financial analyst Geoffrey Porges of SVB Leerink predicted that remdesivir would deliver revenues approaching $2 billion in 2020, rising to $7.7 billion by 2022. These figures are ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...

Leerink Partners has maintained its Outperform rating and $19.00 price target for Tango Therapeutics Inc. (NASDAQ: TNGX). The firm's stance comes ahead of the biotech company's year-end clinical ...

Leerink analyst Marc Goodman assumed coverage of Stoke Therapeutics with an Outperform rating and $18 price target The firm said there is “significant” unmet need for the treatment of Dravet ...

Leerink assumed coverage of Mind Medicine with an Outperform rating and $20 price target The firm likes the emerging psychedelics space with increasing investment in clinical development across ...

Leerink Partners has maintained its Outperform rating on Geron (NASDAQ:GERN) Corporation (NASDAQ: GERN), with a steady price target of $7.00. The firm's stance comes in anticipation of the first ...

Leerink Partners analyst Lili (Aurélie) Nsongo maintained a Buy rating on Sensorion SAS (RFM – Research Report) yesterday. The company’s shares closed yesterday at €0.70. According to ...

In a report released yesterday, Andrew Berens from Leerink Partners maintained a Hold rating on Agios Pharma (AGIO – Research Report). The company’s shares closed yesterday at $41.28.

Leerink Partners has maintained its Outperform rating on Geron (NASDAQ:GERN) Corporation (NASDAQ: GERN), with a steady price target of $7.00. The firm's stance comes in anticipation of the first full ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...